Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity.

Havenga, M J E; Holterman, L; Melis, I; Smits, S; Kaspers, J; Heemskerk, E; van der Vlugt, R; Koldijk, M; Schouten, G J; Hateboer, G; Brouwer, K; Vogels, R; Goudsmit, J

Havenga, M J E; Holterman, L; Melis, I; Smits, S; Kaspers, J; Heemskerk, E; van der Vlugt, R; Koldijk, M; Schouten, G J; Hateboer, G; Brouwer, K; Vogels, R; Goudsmit, J.

Affiliation

Havenga MJ; Crucell Holland BV, PO Box 2048, 2301CA Leiden, The Netherlands. m.havenga@crucell.com

Biotechnol Bioeng ; 100(2): 273-83, 2008 Jun 01.

Article in En | MEDLINE | ID: mdl-18512821

Subject(s)

Adenoviridae/genetics; Genetic Enhancement/methods; Protein Engineering/methods; Recombinant Proteins/metabolism; Retina/metabolism; Transfection/methods; Biotechnology/methods; Cell Line; Culture Media, Serum-Free; Genetic Vectors/genetics; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retina / Recombinant Proteins / Transfection / Protein Engineering / Adenoviridae / Genetic Enhancement Limits: Humans Language: En Journal: Biotechnol Bioeng Year: 2008 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google